Creon 3 (amylase 15,000 UNT / lipase 3000 UNT / protease 9500 UNT) Delayed Release Oral Capsule

RxCUI: 1113046
RxNorm name: Creon 3 (amylase 15,000 UNT / lipase 3000 UNT / protease 9500 UNT) Delayed Release Oral Capsule
Display name: Creon 3 (amylase 15,000 UNT / lipase 3000 UNT / protease 9500 UNT) Delayed Release Oral Capsule
Full name: Creon 3 (amylase 15,000 UNT / lipase 3000 UNT / protease 9500 UNT) Delayed Release Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
020725	Creon	pancrelipase	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Creon	PANCRELIPASE	AbbVie Inc.	073201aa-556d-4a70-918e-84e9616fd88d	2024-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 1113046

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
073201aa-556d-4a70-918e-84e9616fd88d	Creon 3 (amylase 15,000 UNT / lipase 3000 UNT / protease 9500 UNT) Delayed Release Oral Capsule	SY	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228
073201aa-556d-4a70-918e-84e9616fd88d	Creon (amylases 15,000 UNT / endopeptidases 9500 UNT / lipase 3000 UNT) Delayed Release Oral Capsule	SY	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228
073201aa-556d-4a70-918e-84e9616fd88d	Creon 3000 (lipase) Delayed Release Oral Capsule	SY	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228
073201aa-556d-4a70-918e-84e9616fd88d	amylase 15000 UNT / lipase 3000 UNT / protease 9500 UNT Delayed Release Oral Capsule [Creon]	SBD	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228
073201aa-556d-4a70-918e-84e9616fd88d	Creon 3 Delayed Release Oral Capsule	SY	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228
073201aa-556d-4a70-918e-84e9616fd88d	CREON 3000 UNT / 15,000 UNT / 9500 UNT Delayed Release Oral Capsule	PSN	108	These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules , for oral use Initial U.S. Approval: 2009	20240228